Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care, and public health policy for 25 years. He has developed extensive national and international collaborations and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies. Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999 and has led its development into one of the leading national and international HCV treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons.

Nittaya Phanuphak is Executive Director at the Institute of HIV Research and Innovation (IHRI) in Bangkok, Thailand. She has deep interest in the establishment and sustainability of the Key Population-Led Health Services (KPLHS) which empower key population lay providers who are members of key population communities to design and co-deliver sexual and reproductive health, mental health, rights, and harm reduction services to their peers. She provides research support to various implementation science and clinical trial studies as principal investigator or site-principal investigator. She has served as Chair, Co-Chair and member of several WHO Guidelines Development Groups and Strategic and Technical Advisory Committees. She has published more than 300 peer-reviewed articles. She has been the International AIDS Society (IAS) Governing Council Representative of Asia and the Pacific Islands during 2018-2026. She also serves as the Deputy Editor of the Journal of International AIDS Society (JIAS) and the Associate Editor of Sexual Health.

Dr. Thomas (Tommy) Brothers, MD PhD FRCPC, is a general internist and addiction medicine physician in Halifax, Nova Scotia, Canada, and assistant professor of medicine at Dalhousie University. His clinical and research work focuses on improving health services for people who use drugs, and especially the integration of substance use care into general medical and hospital settings. He leads a research program incorporating implementation science, community-based research, and social epidemiology. With many colleagues and friends, Tommy helped to start Atlantic Canada’s first overdose prevention site in 2019 and first hospital-based addiction medicine consult service in 2023.